PMID- 20140891 OWN - NLM STAT- MEDLINE DCOM- 20100520 LR - 20100302 IS - 1521-2254 (Electronic) IS - 1099-498X (Linking) VI - 12 IP - 3 DP - 2010 Mar TI - Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation induced by transduction-associated physical stress. PG - 231-43 LID - 10.1002/jgm.1436 [doi] AB - BACKGROUND: Dendritic cells (DCs) constitute an attractive target for immunotherapeutic approaches. Because DCs are largely refractory to transfection with plasmid DNA, several viral transduction protocols were established. The potential side-effects of lentiviral transduction on the phenotype and activation state of DCs left unstimulated after transduction have not been assessed. There is a need to analyse these parameters as a result of the requirement of using DCs with a low activation state for therapeutic strategies intended to induce tolerance. METHODS: Lentivirally-transduced bone marrow (BM)-derived DCs (LV-DCs) in comparison with mock-transduced (Mock-DCs) and untreated DCs were analysed with regard to the induction of maturation processes on the RNA, protein and functional level. BM-DCs engineered to overexpress interleukin (IL)-10 were analysed for therapeutic potential in a mouse model of allergic contact dermatitis. RESULTS: Compared with untreated DCs, Mock-DCs and LV-DCs displayed an altered gene expression signature. Mock-DCs induced a stronger T cell proliferative response than untreated DCs. LV-DCs did not further augment the T cell proliferative response, but induced a slightly different T cell cytokine pattern compared to Mock-DCs. Accordingly, the gene promoter of the DC maturation marker fascin mediated efficient expression of the model transgene IL-10 in unstimulated-transduced BM-DCs. Nevertheless, IL-10 overexpressing BM-DCs exerted tolerogenic activity and efficiently inhibited the contact hypersensitivity response in previously hapten-sensitized mice. CONCLUSIONS: Lentiviral transduction of BM-DCs results in their partial activation. Nevertheless, the transduction of these DCs with a vector encoding the immunomodulatory cytokine IL-10 rendered them tolerogenic. Thus, lentivirally-transduced DCs expressing immunomodulatory molecules represent a promising tool for induction of tolerance. FAU - Besche, Verena AU - Besche V AD - University Medical Center of the Johannes Gutenberg-University, Clinical Research Unit Allergology, Department of Dermatology, Mainz, Germany. FAU - Wiechmann, Nadine AU - Wiechmann N FAU - Castor, Timo AU - Castor T FAU - Trojandt, Stefanie AU - Trojandt S FAU - Hohn, Yvonne AU - Hohn Y FAU - Kunkel, Hanna AU - Kunkel H FAU - Grez, Manuel AU - Grez M FAU - Grabbe, Stephan AU - Grabbe S FAU - Reske-Kunz, Angelika B AU - Reske-Kunz AB FAU - Bros, Matthias AU - Bros M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Gene Med JT - The journal of gene medicine JID - 9815764 RN - 130068-27-8 (Interleukin-10) SB - IM MH - Animals MH - Dendritic Cells/*immunology/*transplantation MH - Dermatitis, Allergic Contact/*therapy MH - Female MH - Genetic Engineering MH - Immunotherapy MH - Interleukin-10/*genetics MH - Lymphocyte Activation MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Stress, Physiological MH - T-Lymphocytes/*immunology MH - Transduction, Genetic EDAT- 2010/02/09 06:00 MHDA- 2010/05/21 06:00 CRDT- 2010/02/09 06:00 PHST- 2010/02/09 06:00 [entrez] PHST- 2010/02/09 06:00 [pubmed] PHST- 2010/05/21 06:00 [medline] AID - 10.1002/jgm.1436 [doi] PST - ppublish SO - J Gene Med. 2010 Mar;12(3):231-43. doi: 10.1002/jgm.1436.